Parkinson Disease
📧 Sign up to get email alerts when something new happens for Parkinson Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2010-10-04FDA Approved: CARBIDOPA AND LEVODOPA — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approves Sun Pharmaceutical's supplemental application for CARBIDOPA AND LEVODOPA, a generic combination therapy for Parkinson's disease…
-
FDA approval · 2010-10-04FDA Approved: TRIHEXYPHENIDYL HYDROCHLORIDE — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)
The FDA approved a supplemental application for Trihexyphenidyl hydrochloride from PAI Holdings (PAI Pharma), establishing its generic produ…
-
FDA approval · 2010-03-29FDA Approved: BENZTROPINE MESYLATE — Original Application (Cipla USA Inc.)
FDA approves Cipla USA Inc. for the original application of benztropine mesylate as a generic product.
-
FDA approval · 2010-03-24FDA Approved: ROPINIROLE — Original Application (Alembic Pharmaceuticals Limited)
FDA approves Alembic Pharmaceuticals Limited's original ANDA for ropinirole, a generic version of a dopamine agonist used to treat Parkinson…
-
FDA approval · 2010-02-25FDA Approved: ROPINIROLE — Original Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved Glenmark's original ANDA for ropinirole, enabling a generic version of the drug. Ropinirole is used to treat Parkinson's diseas…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2009-12-09FDA Approved: AZILECT — Supplemental Application (Teva Neuroscience, Inc.)
The FDA approved a supplemental application for AZILECT (rasagiline mesylate) submitted by Teva Neuroscience.
-
FDA approval · 2009-12-07FDA Approved: AMANTADINE HYDROCHLORIDE — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)
FDA approved a supplemental application for amantadine hydrochloride from PAI Holdings dba PAI Pharma.
-
FDA approval · 2009-10-30FDA Approved: CARBIDOPA AND LEVODOPA — Supplemental Application (Dr. Reddy's Laboratories Inc)
FDA approved a supplemental application for a generic carbidopa/levodopa product from Dr. Reddy's Laboratories.
-
FDA approval · 2009-10-30FDA Approved: CARBIDOPA AND LEVODOPA — Supplemental Application (Dr. Reddy's Laboratories Inc)
FDA approved a supplemental application for Carbidopa and Levodopa from Dr. Reddy's Laboratories Inc, authorizing the generic product.
-
FDA approval · 2009-10-30FDA Approved: CARBIDOPA AND LEVODOPA — Supplemental Application (Dr. Reddy's Laboratories Inc)
FDA supplemental approval for a generic product of Carbidopa and Levodopa by Dr. Reddy's Laboratories Inc.
-
FDA approval · 2009-10-29FDA Approved: CARBIDOPA AND LEVODOPA — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approves Teva's supplemental application for a generic Carbidopa and Levodopa product.
-
FDA approval · 2009-09-28FDA Approved: CARBIDOPA AND LEVODOPA — Original Application (Mylan Pharmaceuticals Inc.)
FDA approved an original Abbreviated New Drug Application for Carbidopa and Levodopa, a generic treatment for Parkinson's disease, developed…
-
FDA approval · 2009-08-31FDA Approved: BENZTROPINE MESYLATE — Original Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved Hikma Pharmaceuticals USA Inc.'s benztropine mesylate as an original ANDA application (generic).
-
FDA approval · 2009-07-31FDA Approved: CARBIDOPA AND LEVODOPA — Original Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved Sun Pharmaceutical Industries' generic carbidopa/levodopa in an original ANDA submission, expanding access to this Parkinso…
-
FDA approval · 2009-07-28FDA Approved: BENZTROPINE MESYLATE — Original Application (Fresenius Kabi USA, LLC)
FDA approved the original application for benztropine mesylate (generic) by Fresenius Kabi USA, LLC, expanding access to treatment for Parki…
-
FDA approval · 2009-06-30FDA Approved: TASMAR — Supplemental Application (Bausch Health US LLC)
FDA approved a supplemental application for TASMAR (tolcapone) submitted by Bausch Health US LLC.
-
FDA approval · 2009-06-05FDA Approved: AMANTADINE HYDROCHLORIDE — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approves Upsher-Smith Laboratories' supplemental application for amantadine hydrochloride (generic product). This action confirms approv…
-
FDA approval · 2009-06-04FDA Approved: AMANTADINE HYDROCHLORIDE — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved a supplemental application for amantadine hydrochloride from Upsher-Smith Laboratories, LLC.
-
FDA approval · 2009-04-29FDA Approved: AMANTADINE HYDROCHLORIDE — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)
FDA approved a supplemental application for amantadine hydrochloride from PAI Pharma, resulting in labeling changes to the product.
-
FDA approval · 2009-02-09FDA Approved: TASMAR — Supplemental Application (Bausch Health US LLC)
The FDA approved a supplemental application for TASMAR (tolcapone) submitted by Bausch Health US LLC.
-
FDA approval · 2009-02-09FDA Approved: AMANTADINE HYDROCHLORIDE — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved a supplemental application for amantadine hydrochloride submitted by Upsher-Smith Laboratories, LLC.
-
FDA approval · 2009-02-02FDA Approved: CARBIDOPA, LEVODOPA, AND ENTACAPONE — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for Sandoz's carbidopa/levodopa/entacapone product, expanding its labeling for use in Parkinson …
-
FDA approval · 2008-12-31FDA Approved: SINEMET — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for Sinemet (carbidopa/levodopa) submitted by Organon LLC.
-
FDA approval · 2008-10-28FDA Approved: CARBIDOPA AND LEVODOPA — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical Industries' original application for a generic carbidopa and levodopa combination tablet. The drug is indica…
-
FDA approval · 2008-10-01FDA Approved: BROMOCRIPTINE MESYLATE — Original Application (Padagis US LLC)
FDA approved Padagis US LLC's original generic application for bromocriptine mesylate. This approval provides a generic version of bromocrip…